within Pharmacolibrary.Drugs.ATC.G;

model G01AF02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.1,
    Cl             = 20.0,
    adminDuration  = 600,
    adminMass      = 0.05,
    adminCount     = 1,
    Vd             = 0.004,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.002,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Clotrimazole is an imidazole antifungal agent used to treat various fungal infections, including candidiasis and dermatophytoses. It is commonly applied topically or as a vaginal tablet and remains an approved and widely used medication for fungal infections.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are available for oral administration in healthy adult volunteers. Clotrimazole is rarely administered systemically due to significant first-pass metabolism and low systemic absorption following oral or topical dosing.</p><h4>References</h4><ol><li>Takaya Uno, Kyoichi Wada, Sachi Matsuda, Yuka Terada, Nobue Terakawa, Akira Oita, Satoshi Yokoyama, Atsushi Kawase, Kouichi Hosomi, Mitsutaka Takada,Effects of clotrimazole on tacrolimus pharmacokinetics in patients with heart transplants with different CYP3A5 genotypes.,European journal of clinical pharmacology,2019<a href='https://pubmed.ncbi.nlm.nih.gov/30251062/'>https://pubmed.ncbi.nlm.nih.gov/30251062/</a></li><li>B Duhm, H Medenwald, J Puetter, W Maul, K Patzschke, L A Wegner,The pharmacokinetics of clotrimazole 14C.,Postgraduate medical journal,1974<a href='https://pubmed.ncbi.nlm.nih.gov/4467160/'>https://pubmed.ncbi.nlm.nih.gov/4467160/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G01AF02;
